Functional aspects of 17β-estradiol dehydrogenase
Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition

https://doi.org/10.1016/0960-0760(95)00209-XGet rights and content

Abstract

Following transfection of types 1, 2 and 3 17β-hydroxysteroid dehydrogenase (17β-HSD) cDNAs into transformed embryonal kidney (293) cells, we have characterized the selective directional and inhibitory characteristics of these activities. While homogenates of transfected cells could catalyze interconversion of the substrate and product, in agreement with the general belief on the activity of these enzymes, the same activities measured in intact cells, in order to better reflect the physiological conditions, showed an unidirectional reaction. Types 1 and 3 17β-HSD catalyzed the reduction of estrone to estradiol and 4-androstenedione to testosterone, respectively, while type 2 17β-HSD catalyzed the oxidative transformation of both testosterone and 17β-estradiol to 4-androstenedione and estrone, respectively. In addition, types 1, 2 and 3 17β-HSD activities showed different pH optima. While types 1 and 3 showed pH optimum values centered at around 5 and 6, respectively, type 2 17β-HSD activity, which preferentially catalyzes the oxidation reaction, has higher activity at an alkaline pH (8–10). Differences in the optimum incubation temperatures were also observed: type 1 17β-HSD shows a relatively high temperature tolerance (55°C). In contrast, type 2 and 3 functioned best at 37°C. Types 1, 2 and 3 17β-HSD activities could be also differentiated by their sensitivity toward various specific inhibitors: type 1 was potently inhibited by an estradiol derivative containing a bromo/or iodopropyl group at position 16α. On the other hand a derivative of estrone containing a spiro-γ-lactone at position 17 showed a potent inhibitory effect on type 2 17β-HSD, whereas type 3 was strongly inhibited by 1,4-androstadiene-1,6,17-trione.

References (36)

  • V. Luu-The et al.

    Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes

    Molec. Endocr.

    (1990)
  • C.H. Blomquist et al.

    Steroid modulation of 17β-hydroxysteroid oxidoreductase activities in human placental villi in vitro

    J. Clin. Endocr. Metab.

    (1987)
  • D.E. Pittaway et al.

    Human ovarian 17β-hydroxysteroid oxidoreductase activity

    A comparison of normal and polycystic ovarian tissues

    J. Clin. Endocr. Metab.

    (1983)
  • H. Inano et al.

    Testicular 17β-hydroxysteroid dehydrogenase: molecular properties and reaction mechanism

    Steroids

    (1986)
  • W.M. Geissler et al.

    Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3

    Nature Genet.

    (1994)
  • G. Bleau et al.

    The in vitro and in vivo uptake and metabolism of steroid in human adipose tissue

    J. Clin. Endocr. Metab.

    (1974)
  • L. Tseng et al.

    Quantitative studies on the uptake and metabolism of estrogens and progesterone by human endometrium

    Endocrinology

    (1972)
  • H. Breuer et al.

    Metabolism of oestrone and oestradiol-17β in human liver in vitro

    Nature

    (1966)
  • Cited by (224)

    • Intracrinology-revisited and prostate cancer

      2020, Journal of Steroid Biochemistry and Molecular Biology
    View all citing articles on Scopus
    View full text